Vera Therapeutics, Inc. (VERA)
NASDAQ$27.99
Market Cap
$1.78B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
901 of 924
Rank in Industry
515 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
VERA Insider Trading Activity
VERA Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $53,132,993 | 26 | 100 |
Related Transactions
| SEIDENBERG BETH C | director | 0 | $0 | 3 | $1.42M | $-1.42M |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | 0 | $0 | 3 | $1.53M | $-1.53M |
| Grant Sean | CHIEF FINANCIAL OFFICER | 0 | $0 | 1 | $4.69M | $-4.69M |
| Fordyce Marshall | PRESIDENT AND CEO | 0 | $0 | 16 | $11.39M | $-11.39M |
| Katabi Maha | director | 0 | $0 | 3 | $34.1M | $-34.1M |
About Vera Therapeutics, Inc.
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode …
Insider Activity of Vera Therapeutics, Inc.
Over the last 12 months, insiders at Vera Therapeutics, Inc. have bought $0 and sold $53.13M worth of Vera Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Vera Therapeutics, Inc. have bought $59.02M and sold $25.29M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 161,290 shares for transaction amount of $5M was made by Katabi Maha (director) on 2024‑01‑30.
List of Insider Buy and Sell Transactions, Vera Therapeutics, Inc.
| 2025-02-26 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 9,075 0.0145% | $27.65 | $250,882 | +1.02% | |
| 2025-02-21 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 10,613 0.0158% | $27.89 | $296,032 | -1.36% | |
| 2025-01-08 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 17,500 0.0275% | $41.74 | $730,535 | -20.51% | |
| 2024-12-18 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 17,500 0.0289% | $43.07 | $753,680 | -17.36% | |
| 2024-12-18 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 15,625 0.0257% | $42.98 | $671,536 | -17.36% | |
| 2024-12-18 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 3,772 0.006% | $41.33 | $155,883 | -17.36% | |
| 2024-12-11 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 17,500 0.0277% | $46.94 | $821,523 | -25.36% | |
| 2024-11-25 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 19,375 0.0313% | $47.98 | $929,560 | -22.70% | |
| 2024-11-13 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 30,625 0.048% | $49.50 | $1.52M | -24.18% | |
| 2024-10-28 | Sale | SEIDENBERG BETH C | director | 15,000 0.0323% | $48.03 | $720,493 | -12.63% | |
| 2024-10-23 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 19,375 0.0351% | $40.39 | $782,610 | +3.35% | |
| 2024-10-09 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 15,625 0.0239% | $38.24 | $597,568 | +4.80% | |
| 2024-09-25 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 22,225 0.0419% | $46.02 | $1.02M | -9.03% | |
| 2024-09-19 | Sale | SEIDENBERG BETH C | director | 13,823 0.0254% | $42.31 | $584,793 | -2.06% | |
| 2024-09-18 | Sale | SEIDENBERG BETH C | director | 2,653 0.005% | $42.01 | $111,440 | +2.06% | |
| 2024-09-11 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 15,625 0.0285% | $37.50 | $585,934 | +8.77% | |
| 2024-08-28 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 30,320 0.0555% | $36.84 | $1.12M | +10.03% | |
| 2024-08-21 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 14,471 0.0263% | $39.76 | $575,425 | +0.66% | |
| 2024-08-14 | Sale | Fordyce Marshall | PRESIDENT AND CEO | 15,625 0.03% | $37.56 | $586,927 | +5.80% | |
| 2024-05-16 | Sale | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | 20,651 0.037% | $42.32 | $873,890 | -9.41% |
Total: 97
*Gray background shows transactions not older than one year
Insider Historical Profitability
80.63%
| Katabi Maha | director | 2793987 4.3828% | $78.2M | 2 | 3 | +37.14% |
| SEIDENBERG BETH C | director | 131553 0.2064% | $3.68M | 19 | 3 | +96.79% |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | 51206 0.0803% | $1.43M | 2 | 3 | +91.54% |
| Grant Sean | CHIEF FINANCIAL OFFICER | 0 0% | $0 | 4 | 1 | +48.2% |
| COMMODORE CAPITAL LP | 10 percent owner | 4400000 6.9021% | $123.16M | 1 | 1 | +19.9% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$66,492,695 | 135 | 27.65% | $2.04B | |
$831,902,292 | 108 | 9.34% | $1.58B | |
$20,297,544 | 73 | 103.06% | $1.61B | |
$11,583,737 | 45 | 49.75% | $1.75B | |
$224,267,561 | 40 | 26.78% | $2.17B |
VERA Institutional Investors: Active Positions
| Increased Positions | 134 | +100.75% | 13M | +25.23% |
| Decreased Positions | 60 | -45.11% | 4M | -7.28% |
| New Positions | 33 | New | 2M | New |
| Sold Out Positions | 25 | Sold Out | 690,705 | Sold Out |
| Total Postitions | 207 | +55.64% | 63M | +17.95% |
VERA Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Avoro Capital Advisors Llc | $167,907.00 | 8.9% | 5.61M | +1M | +30.18% | 2024-12-31 |
| Price T Rowe Associates Inc /Md/ | $131,005.00 | 6.95% | 4.38M | +437,940 | +11.12% | 2024-12-31 |
| Blackrock, Inc. | $117,969.00 | 6.26% | 3.94M | +489,284 | +14.17% | 2024-12-31 |
| Fmr Llc | $91,380.00 | 4.85% | 3.05M | +267,842 | +9.62% | 2024-12-31 |
| Vanguard Group Inc | $88,280.00 | 4.68% | 2.95M | +369,387 | +14.32% | 2024-12-31 |
| Sofinnova Investments, Inc. | $83,624.00 | 4.43% | 2.79M | 0 | 0% | 2024-12-31 |
| State Street Corp | $60,649.00 | 3.22% | 2.03M | +202,545 | +11.11% | 2024-12-31 |
| Commodore Capital Lp | $58,621.00 | 3.11% | 1.96M | -516,400 | -20.86% | 2024-12-31 |
| Holocene Advisors, Lp | $56,148.00 | 2.98% | 1.88M | -78,565 | -4.02% | 2024-12-31 |
| Samlyn Capital, Llc | $49,750.00 | 2.64% | 1.66M | +302,993 | +22.29% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.